Limes Schlosskliniken AG

Limes Schlosskliniken AG maintains a strong liquidity position with a current ratio of 2.92, indicating the company can cover its short-term obligations more than two and a half times over. However, the company's liquidity risk is assessed as medium, primarily due to a negative net cash position after subtracting total debt. The price-to-book ratio of 8.08 suggests that the market is valuing the company's equity at a premium relative to its book value. In terms of profitability, the company's return on equity (ROE) of 16.98% and return on assets (ROA) of 8.07% indicate strong returns relative to its equity and asset base. These metrics are typically compared against industry medians to assess relative performance, but the company's performance appears robust given the high ROE and ROA figures. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration may expose the company to higher operational and market risks if the segment faces challenges. Looking at the growth trajectory, the company's capital expenditures of -4.97 million EUR suggest a reduction in investment in physical assets, which could indicate a shift in strategic focus or a response to market conditions. Analysts have set a mean price target of 647.50 EUR, with a median of 647.50 EUR, indicating a consensus for potential upside in the stock price. The company's risk profile includes a low dilution potential, with no significant dilution sources identified in the risk assessment. However, the negative net cash position after subtracting total debt is a key flag that investors should monitor. The company's valuation is supported by a price-to-earnings ratio of 47.58 and an enterprise value-to-EBITDA ratio of 36.97, which are relatively high and suggest that the market is pricing in strong future earnings growth. Recent events and filings have not indicated any major operational or financial disruptions, and the company's financial statements do not show any significant red flags that would suggest immediate risk to its operations or financial health.